Pipeline

Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases

Pipeline

COVID-19 Vaccine

Pipeline Antigen gene Basic research Preclinical experiment Phase of Clinical trial
Phase Ⅰ Phase Ⅱ Phase Ⅲ
AdCLD-CoV19-1 SARS-CoV-2 Spike
protein

NCT Identifier :

  • Indication : COVID-19 prevention
  • Clinical Trial Stage : Phase IIb Clinical Trial
  • Clinical Trial Purpose : To evaluated safety and immunogenicity of AdCLD-CoV19
  • Clinical Trial Result : In progress
AdCLD-CoV19-1 OMI SARS-CoV-2 B.1.1.529
spike protein 재조합유전자

NCT Identifier : TBA

  • Indication : COVID-19 Omicron prevention
  • Clinical Trial Stage : Phase1/2 IIb Clinical Trial
  • Clinical Trial Purpose : To evaluated safety and immunogenicity of AdCLD-CoV19 OMI
  • Clinical Trial Result : In progress
  • AdCLD-CoV19-1

    SARS-CoV-2 Spike protein

    Basic research Preclinical experiment Phase Ⅰ Phase Ⅱ Phase Ⅲ

    NCT Identifier :

    • Indication : COVID-19 prevention
    • Clinical Trial Stage : Phase IIb Clinical Trial
    • Clinical Trial Purpose : To evaluated safety and immunogenicity of AdCLD-CoV19
    • Clinical Trial Result : In progress
  • AdCLD-CoV19-1 OMI

    SARS-CoV-2 B.1.1.529 spike protein 재조합유전자

    Basic research Preclinical experiment Phase Ⅰ Phase Ⅱ Phase Ⅲ

    NCT Identifier : TBA

    • Indication : COVID-19 Omicron prevention
    • Clinical Trial Stage : Phase1/2 IIb Clinical Trial
    • Clinical Trial Purpose : To evaluated safety and immunogenicity of AdCLD-CoV19 OMI
    • Clinical Trial Result : In progress